Lucon Pharma and Research Private Limited
About Lucon Pharma and Research Private Limited
Data last updated:
Lucon Pharma and Research Private Limited is a private limited company based in Roorkee, Uttarakhand, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 25 June 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Uttarakhand, under CIN U24304UR2019PTC009957. Its GSTIN is 05AADCL9650P1ZX (Uttarakhand).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sanjeev Kumar Saini and Dara Singh.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 476/3 Chaw Mandi Roorkee, Uttarakhand, India – 247667.
As per the financials filed for FY 2024, the company reported a revenue of ₹71.82 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹16.5 Lakh (net margin -23%) and EBITDA of -₹16.38 Lakh (EBITDA margin -22.8%). Revenue has grown at a compounded annual rate (CAGR) of 38% over three years.
Court records list 10 cases involving the company, including 10 filed against it; 9 cases are pending.
Company details
Contact details
Lucon Pharma and Research Private Limited's registered office is in Roorkee, Uttarakhand. Its e-mail address is in the company report.
- Email
- Registered Address476/3 Chaw Mandi Roorkee, Uttarakhand, India – 247667
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Lucon Pharma and Research Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Lucon Pharma and Research is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Lucon Pharma and Research Private Limited, buy the company report.
Financials of Lucon Pharma and Research Private Limited
FY 2024 filings availableLucon Pharma and Research Private Limited reported revenue of ₹71.82 Lakh (up 476% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 38% over three years, including 476% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹16.38 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹16.5 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -22.8% | ||||
| Net Profit Margin | -23% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Lucon Pharma and Research Private Limited, buy the company report.
Board of directors of Lucon Pharma and Research Private Limited
Lucon Pharma and Research has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanjeev Kumar Saini | Director | 25 Jun 2019 | 7 Years 4 Months | Current |
| Dara Singh | Additional Director | 01 Jul 2024 | 2 Years 4 Months | Current |
Peer comparison
Lucon Pharma and Research Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ameren Shipx Services Private Limited | ₹72.42 Lakh (FY 2024) | -37.0% | Nagpur, Maharashtra, India | |||
| Lucon Pharma and Research Private Limitedthis company | ₹71.82 Lakh (FY 2024) | -₹16.5 Lakh | -23% | 476.0% | Roorkee, Uttarakhand, India | |
| Xylia Pharmaceuticals Private Limited | ₹71.26 Lakh (FY 2025) | -7.0% | Kozhikode, Kerala, India | |||
| Nevuron India Private Limited | ₹70.92 Lakh (FY 2025) | 20.0% | New Delhi, Delhi, India |
To see the full peer comparison of Lucon Pharma and Research Private Limited, buy the company report.
Legal cases
Lucon Pharma and Research Private Limited has 10 court cases on record: 10 filed against it. 9 cases are pending and 1 is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 10 | 10 | 9 |
Cases on record (4 of 10)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Haridwar, Uttarakhand | Criminal case | Filed against the company by M/S Vivotex Pharma LLP | Pending |
| District court, Palwal, Haryana | Cheque dishonour complaint | Filed against the company by Globin Pharmaceuticals Pvt. Ltd. | Pending |
| District court, Palwal, Haryana | Cheque dishonour complaint | Filed against the company by Globin Pharmacheuticals Pvt. Ltd. | Pending |
| District court, Ahmedabad, Gujarat | Criminal complaint | Filed against the company by Reshma Ruchitkumar Virda Prop. of Addranine India Pharma | Disposed |
To see the full case history of Lucon Pharma and Research Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Lucon Pharma and Research Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Lucon Pharma and Research has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AADCL9650P1ZX | Uttarakhand | Active | 01 Sep 2019 |
To see the full GST registrations and return filing status of Lucon Pharma and Research Private Limited, buy the company report.
Recent activity
Lucon Pharma and Research Private Limited has 10 board changes on record since 2019: 6 appointments and 4 cessations. The latest: Harish Chandar Thukral ceased to be Additional Director on 20 Aug 2024.
1 earlier event is in the company report.
Frequently asked questions
Lucon Pharma and Research is an active private limited company based in Roorkee, Uttarakhand, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 25 June 2019 (7+ years old) and is registered under CIN U24304UR2019PTC009957.
Lucon Pharma and Research has 2 current directors:
- Sanjeev Kumar Saini - Director
- Dara Singh - Additional Director
The latest financial statements of Lucon Pharma and Research on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Lucon Pharma and Research is 05AADCL9650P1ZX, registered in Uttarakhand.
The CIN (Corporate Identification Number) of Lucon Pharma and Research is U24304UR2019PTC009957. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lucon Pharma and Research has 10 court cases on record: 10 filed against it. 9 are pending.
Lucon Pharma and Research was incorporated on 25 June 2019, making it 7+ years old. It is registered with the Registrar of Companies, Uttarakhand.
The peers of Lucon Pharma and Research by revenue are Ameren Shipx Services Private Limited, Xylia Pharmaceuticals Private Limited, Nevuron India Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).
Harish Chandar Thukral ceased to be Additional Director on 20 Aug 2024. Yahya Abdulrahman Salem ceased to be Additional Director on 20 Aug 2024. Dara Singh was appointed as Additional Director on 01 Jul 2024. Lucon Pharma and Research has 10 board changes on record in total.
The registered office of Lucon Pharma and Research is at 4763 Chaw Mandi Roorkee, Uttarakhand, India – 247667.
Lucon Pharma and Research operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
